PT1365768E - Utilização de antagonistas selectivos para er-beta como contraceptivos - Google Patents
Utilização de antagonistas selectivos para er-beta como contraceptivos Download PDFInfo
- Publication number
- PT1365768E PT1365768E PT02706750T PT02706750T PT1365768E PT 1365768 E PT1365768 E PT 1365768E PT 02706750 T PT02706750 T PT 02706750T PT 02706750 T PT02706750 T PT 02706750T PT 1365768 E PT1365768 E PT 1365768E
- Authority
- PT
- Portugal
- Prior art keywords
- contraceptives
- selective antagonists
- beta selective
- erss
- antagonists
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 229940124558 contraceptive agent Drugs 0.000 title 1
- 239000003433 contraceptive agent Substances 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27140901P | 2001-02-27 | 2001-02-27 | |
| DE10151365A DE10151365A1 (de) | 2001-10-17 | 2001-10-17 | 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten |
| US32973601P | 2001-10-18 | 2001-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1365768E true PT1365768E (pt) | 2008-07-29 |
Family
ID=27214634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02706750T PT1365768E (pt) | 2001-02-27 | 2002-02-27 | Utilização de antagonistas selectivos para er-beta como contraceptivos |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1365768B1 (pt) |
| JP (1) | JP2004529107A (pt) |
| AT (1) | ATE394106T1 (pt) |
| AU (1) | AU2002240936A1 (pt) |
| DE (1) | DE60226416D1 (pt) |
| DK (1) | DK1365768T3 (pt) |
| ES (1) | ES2305210T3 (pt) |
| PT (1) | PT1365768E (pt) |
| UY (1) | UY27189A1 (pt) |
| WO (1) | WO2002068548A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004032673A1 (de) * | 2004-07-02 | 2006-01-26 | Schering Ag | Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1 |
| CN101052641A (zh) | 2004-09-07 | 2007-10-10 | 惠氏公司 | 6H－[1]苯并吡喃并[4,3－b]喹啉及其作为雌激素药物的用途 |
| US9284345B2 (en) | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK23984A (da) * | 1983-02-11 | 1984-08-12 | Hoffmann La Roche | D-homosteroider |
| EP1080507A1 (en) * | 1998-05-01 | 2001-03-07 | Eveready Battery Company, Inc. | Heat treated fine carbon for alkaline manganese cathodes |
| DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
| DE19917930A1 (de) * | 1999-04-15 | 2000-10-19 | Schering Ag | Ent-Steroide als selektiv wirksame Estrogene |
-
2002
- 2002-02-27 DK DK02706750T patent/DK1365768T3/da active
- 2002-02-27 JP JP2002568649A patent/JP2004529107A/ja active Pending
- 2002-02-27 AU AU2002240936A patent/AU2002240936A1/en not_active Abandoned
- 2002-02-27 DE DE60226416T patent/DE60226416D1/de not_active Expired - Fee Related
- 2002-02-27 PT PT02706750T patent/PT1365768E/pt unknown
- 2002-02-27 WO PCT/EP2002/002117 patent/WO2002068548A1/en not_active Ceased
- 2002-02-27 AT AT02706750T patent/ATE394106T1/de not_active IP Right Cessation
- 2002-02-27 ES ES02706750T patent/ES2305210T3/es not_active Expired - Lifetime
- 2002-02-27 EP EP02706750A patent/EP1365768B1/en not_active Expired - Lifetime
- 2002-02-27 UY UY27189A patent/UY27189A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002068548A9 (en) | 2003-02-20 |
| WO2002068548A8 (en) | 2003-12-24 |
| WO2002068548A3 (en) | 2003-06-05 |
| AU2002240936A1 (en) | 2002-09-12 |
| EP1365768A2 (en) | 2003-12-03 |
| WO2002068548A1 (en) | 2002-09-06 |
| ES2305210T3 (es) | 2008-11-01 |
| UY27189A1 (es) | 2002-09-30 |
| JP2004529107A (ja) | 2004-09-24 |
| ATE394106T1 (de) | 2008-05-15 |
| DK1365768T3 (da) | 2008-08-18 |
| EP1365768B1 (en) | 2008-05-07 |
| DE60226416D1 (de) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69617732D1 (de) | Transdermales estradiol/progestogen-pflaster und dessen herstellung | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| ATE223413T1 (de) | Neuartige verbindungen | |
| ATE226205T1 (de) | Verbindungen | |
| MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
| MXPA04004939A (es) | 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion. | |
| HUT75930A (en) | Progesterone antagonists useful preparing medicaments for treating dysfunctional uterine bleeding | |
| YU7804A (sh) | Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova | |
| IL166432A0 (en) | Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition | |
| TNSN03043A1 (en) | 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
| NZ530587A (en) | Diazacycloalkanes as oxytocin agonists | |
| PT1365768E (pt) | Utilização de antagonistas selectivos para er-beta como contraceptivos | |
| BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
| MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
| BG105204A (en) | Salts of paroxetine | |
| BG106534A (en) | Oral solution containing galanthamine and a sweetening agent | |
| BR9806210A (pt) | Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio. | |
| MX9710093A (es) | Uso de aminas alilicas. | |
| BG106078A (en) | Thio-oxindole derivatives | |
| WO2003039455A3 (en) | Methods of treating endometreosis | |
| WO1996028154A3 (de) | Verwendung von antiestrogenen zur männlichen fertilitätskontrolle | |
| MX9803605A (es) | Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos. | |
| MY134931A (en) | Oral galantamine solution | |
| MX9606264A (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas. |